Portfolio Holdings Detail for ISIN IE00BYZK4776

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares Healthcare Innovation UCITS ETF USD (Acc) MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-12-18 (Thursday)	185,293	USD 18,657,152	USD 18,657,152	0	USD 279,792	USD 100.69	USD 99.18
2025-12-17 (Wednesday)	185,293	USD 18,377,360	USD 18,377,360	-789	USD 91,082	USD 99.18	USD 98.27
2025-12-16 (Tuesday)	186,082	USD 18,286,278	USD 18,286,278	-789	USD -449,408	USD 98.27	USD 100.26
2025-12-15 (Monday)	186,871	USD 18,735,686	USD 18,735,686	0	USD -7,475	USD 100.26	USD 100.3
2025-12-12 (Friday)	186,871	USD 18,743,161	USD 18,743,161	0	USD 241,063	USD 100.3	USD 99.01
2025-12-11 (Thursday)	186,871	USD 18,502,098	USD 18,502,098	0	USD 259,751	USD 99.01	USD 97.62
2025-12-10 (Wednesday)	186,871	USD 18,242,347	USD 18,242,347	0	USD 136,416	USD 97.62	USD 96.89
2025-12-09 (Tuesday)	186,871	USD 18,105,931	USD 18,105,931	0	USD -381,217	USD 96.89	USD 98.93
2025-12-08 (Monday)	186,871	USD 18,487,148	USD 18,487,148	0	USD -147,628	USD 98.93	USD 99.72
2025-12-05 (Friday)	186,871	USD 18,634,776	USD 18,634,776	0	USD -218,639	USD 99.72	USD 100.89
2025-12-04 (Thursday)	186,871	USD 18,853,415	USD 18,853,415	0	USD -257,882	USD 100.89	USD 102.27
2025-12-03 (Wednesday)	186,871	USD 19,111,297	USD 19,111,297	1,156	USD 348,511	USD 102.27	USD 101.03
2025-12-02 (Tuesday)	185,715	USD 18,762,786	USD 18,762,786	784	USD -68,738	USD 101.03	USD 101.83

Share Trades of MRK by Blackrock for IE00BYZK4776

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-17	SELL	-789	100.135	98.060	98.267	GBX -77,533	89.07 Loss of -7,256 on sale
2025-12-16	SELL	-789	100.340	96.790	97.145	GBX -76,647	89.03 Loss of -6,403 on sale
2025-12-03	BUY	1,156	103.090	101.520	101.677	GBX 117,539	88.59
2025-12-02	BUY	784	101.800	100.310	100.459	GBX 78,760	88.53
2025-12-01	BUY	1,568	105.680	101.710	102.107	GBX 160,104	88.46
2025-11-28	BUY	804	105.405	104.120	104.249	GBX 83,816	88.39
2025-11-14	SELL	-1,572	95.075	91.490	91.849	GBX -144,386	87.88 Loss of -6,241 on sale
2025-10-24	SELL	-1,560	88.060	87.108	87.203	GBX -136,037	87.94 Profit of 1,154 on sale
2025-09-11	BUY	781			85.150*		88.37
2025-07-08	SELL	-780	82.380	80.350	80.553	GBX -62,831	88.89 Profit of 6,502 on sale
2025-06-24	SELL	-777	81.460	79.090	79.327	GBX -61,637	89.44 Profit of 7,858 on sale
2025-06-23	BUY	130	80.220	78.990	79.113	GBX 10,285	89.51
2025-06-20	BUY	78,061	79.920	78.600	78.732	GBX 6,145,899	89.58
2025-06-11	SELL	-456	81.680	79.980	80.150	GBX -36,548	90.08 Profit of 4,527 on sale
2025-05-30	SELL	-456			76.840*		90.84 Profit of 41,424 on sale
2025-05-21	BUY	456	78.100	76.870	76.993	GBX 35,109	91.66
2025-05-14	SELL	-2,730			73.470*		92.22 Profit of 251,760 on sale
2025-04-30	SELL	-455	85.830	83.790	83.994	GBX -38,217	93.37 Profit of 4,268 on sale
2025-04-28	SELL	-455	83.680	82.400	82.528	GBX -37,550	93.56 Profit of 5,020 on sale
2025-04-25	SELL	-455	83.280	78.060	78.582	GBX -35,755	93.67 Profit of 6,864 on sale
2025-04-11	SELL	-2,736	79.440	76.360	76.668	GBX -209,764	94.99 Profit of 50,136 on sale
2025-04-08	SELL	-1,368	83.270	77.540	78.113	GBX -106,859	95.52 Profit of 23,807 on sale
2025-04-07	BUY	1,297	83.210	79.300	79.691	GBX 103,359	95.68
2025-03-31	SELL	-894			89.760*		96.13 Profit of 85,939 on sale
2025-03-21	SELL	-894			93.110*		96.62 Profit of 86,380 on sale
2025-03-12	SELL	-448			93.350*		96.84 Profit of 43,384 on sale
2025-02-28	SELL	-448	92.350	90.710	90.874	GBX -40,712	97.24 Profit of 2,850 on sale
2025-02-25	BUY	448	93.060	90.440	90.702	GBX 40,634	97.57
2025-02-20	SELL	-448	87.700	85.900	86.080	GBX -38,564	98.00 Profit of 5,340 on sale
2025-02-19	BUY	896	85.630	82.850	83.128	GBX 74,483	98.22
2025-02-18	BUY	448	83.590	81.040	81.295	GBX 36,420	98.49
2024-12-30	BUY	923	99.570	98.270	98.400	GBX 90,823	102.04
2024-12-06	SELL	-440	103.950	102.690	102.816	GBX -45,239	101.99 Loss of -366 on sale
2024-12-04	SELL	-440	102.090	101.050	101.154	GBX -44,508	101.95 Profit of 352 on sale
2024-12-03	SELL	-880	102.450	100.620	100.803	GBX -88,707	101.96 Profit of 1,016 on sale
2024-11-22	BUY	854	101.790	98.930	99.216	GBX 84,730	102.18
2024-11-21	SELL	-438	100.480	96.950	97.303	GBX -42,619	102.30 Profit of 2,188 on sale
2024-11-20	SELL	-439	98.840	96.660	96.878	GBX -42,529	102.57 Profit of 2,498 on sale
2024-11-19	SELL	-439	97.550	95.260	95.489	GBX -41,920	102.92 Profit of 3,263 on sale
2024-11-18	SELL	-1,748	97.290	95.420	95.607	GBX -167,121	103.32 Profit of 13,483 on sale
2024-11-12	SELL	-437	100.760	98.500	98.726	GBX -43,143	103.64 Profit of 2,146 on sale
2024-11-07	SELL	-437	101.690	100.850	100.934	GBX -44,108	103.88 Profit of 1,288 on sale
2024-11-05	SELL	-874	101.730	100.520	100.641	GBX -87,960	104.37 Profit of 3,260 on sale
2024-10-28	SELL	-437	105.000	103.930	104.037	GBX -45,464	105.84 Profit of 790 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy